BE901456A - Nouvelles 8 alpha-acylaminoergolines, leur preparation et leur utilisation comme medicaments. - Google Patents
Nouvelles 8 alpha-acylaminoergolines, leur preparation et leur utilisation comme medicaments.Info
- Publication number
- BE901456A BE901456A BE1/11168A BE1011168A BE901456A BE 901456 A BE901456 A BE 901456A BE 1/11168 A BE1/11168 A BE 1/11168A BE 1011168 A BE1011168 A BE 1011168A BE 901456 A BE901456 A BE 901456A
- Authority
- BE
- Belgium
- Prior art keywords
- acylaminoergolins
- news
- medicines
- alpha
- preparation
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- 102000003946 Prolactin Human genes 0.000 abstract 1
- 108010057464 Prolactin Proteins 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Chemical group 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- -1 cycloaliphatic Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 229940097325 prolactin Drugs 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
- C07D457/12—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3400853 | 1984-01-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE901456A true BE901456A (fr) | 1985-07-08 |
Family
ID=6224786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE1/11168A BE901456A (fr) | 1984-01-12 | 1985-01-08 | Nouvelles 8 alpha-acylaminoergolines, leur preparation et leur utilisation comme medicaments. |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US4950672A (OSRAM) |
| JP (1) | JPH0655739B2 (OSRAM) |
| AT (1) | AT391317B (OSRAM) |
| AU (3) | AU583489B2 (OSRAM) |
| BE (1) | BE901456A (OSRAM) |
| CA (1) | CA1245640A (OSRAM) |
| CH (1) | CH664568A5 (OSRAM) |
| CY (1) | CY1542A (OSRAM) |
| DE (1) | DE3500251C2 (OSRAM) |
| DK (1) | DK169891B1 (OSRAM) |
| ES (1) | ES8605514A1 (OSRAM) |
| FI (1) | FI82466C (OSRAM) |
| FR (1) | FR2560196B1 (OSRAM) |
| GB (1) | GB2152507B (OSRAM) |
| GR (1) | GR850065B (OSRAM) |
| HK (1) | HK48590A (OSRAM) |
| HU (1) | HU197569B (OSRAM) |
| IE (1) | IE58228B1 (OSRAM) |
| IL (1) | IL74043A (OSRAM) |
| IT (1) | IT1214648B (OSRAM) |
| LU (1) | LU85725A1 (OSRAM) |
| NL (1) | NL193541C (OSRAM) |
| NZ (1) | NZ210818A (OSRAM) |
| PH (1) | PH23286A (OSRAM) |
| PT (1) | PT79818B (OSRAM) |
| SE (1) | SE460420B (OSRAM) |
| SG (1) | SG32390G (OSRAM) |
| ZA (1) | ZA85276B (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL193541C (nl) * | 1984-01-12 | 2000-01-04 | Novartis Ag | 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten. |
| DE3587860D1 (de) * | 1984-04-09 | 1994-07-28 | Schering Ag | 2-substituierte Ergolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel. |
| NL8700046A (nl) * | 1986-01-24 | 1987-08-17 | Sandoz Ag | 8 alfa-acylaminoergolinen, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten. |
| US4931447A (en) * | 1987-06-15 | 1990-06-05 | Eli Lilly And Company | Cycloalkylamides of (8β)-1-alkyl-6-(substituted) ergolines |
| US4981859A (en) * | 1987-06-15 | 1991-01-01 | Cycloalkylamides of (8 beta )-1-alkyl-6-(substituted)ergolines | |
| IT1219652B (it) * | 1987-06-23 | 1990-05-24 | Sandoz Ag | 8-acilamminoergolina,la sua preparazione e il suo impiego come medicamneto |
| DE3820159A1 (de) * | 1987-06-23 | 1989-01-05 | Sandoz Ag | 8(alpha)-acylaminoergolin, seine herstellung und dieses enthaltende arzneimittel |
| DK338789A (da) * | 1988-07-15 | 1990-01-16 | Schering Ag | 2-substituerede ergolinylurinstofderivater og fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler samt mellemprodukter til fremstilling deraf |
| GB8824744D0 (en) * | 1988-10-21 | 1988-11-30 | Erba Carlo Spa | Antiemesis ergoline derivatives |
| DE3915950A1 (de) * | 1989-05-12 | 1990-11-15 | Schering Ag | 8(alpha)-acylamino-ergoline, ihre herstellung und verwendung als arzneimittel |
| EP3247357A4 (en) * | 2015-01-20 | 2018-07-11 | Xoc Pharmaceuticals, Inc | Isoergoline compounds and uses thereof |
| CN113149982A (zh) | 2015-01-20 | 2021-07-23 | Xoc制药股份有限公司 | 麦角灵化合物及其用途 |
| BR112019025420A2 (pt) | 2017-06-01 | 2020-06-16 | Xoc Pharmaceuticals, Inc. | Compostos policíclicos e usos destes |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3218323A (en) * | 1965-11-16 | Esters of i,g-dimethyl-b-ergolenyl carbamic acid | ||
| US2864822A (en) * | 1956-10-22 | 1958-12-16 | Lilly Co Eli | 9-amino-7-methyl-belta10-ergolene and derivatives thereof |
| CH622519A5 (en) * | 1974-07-05 | 1981-04-15 | Hoechst Ag | Process for the preparation of hydroxyalkylxanthines |
| US4348392A (en) * | 1974-07-19 | 1982-09-07 | Sandoz Ltd. | 8α-Substituted ergoline-I derivatives |
| GB1517971A (en) * | 1974-07-19 | 1978-07-19 | Sandoz Ltd | 8alpha-substituted ergoline i derivatives |
| US3922347A (en) * | 1974-12-19 | 1975-11-25 | Lilly Co Eli | Method of inhibiting prolactin secretion with 8-acylaminoergolenes |
| CH615929A5 (en) * | 1975-06-02 | 1980-02-29 | Sandoz Ag | Process for the preparation of novel ergoline compounds |
| DE2656344A1 (de) * | 1975-12-23 | 1977-07-07 | Sandoz Ag | Ergolinderivate, ihre verwendung und herstellung |
| CH622518A5 (en) * | 1976-12-14 | 1981-04-15 | Sandoz Ag | Process for the preparation of novel ergoline compounds |
| CH644606A5 (de) * | 1980-09-23 | 1984-08-15 | Sandoz Ag | Verfahren zur isomerisierung von 9,10-dihydrolysergsaeurederivaten. |
| DE3151912A1 (de) * | 1981-12-23 | 1983-06-30 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel |
| NL193541C (nl) * | 1984-01-12 | 2000-01-04 | Novartis Ag | 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten. |
| CH666035A5 (de) * | 1984-12-24 | 1988-06-30 | Sandoz Ag | 8-alpha-acylaminoergolene. |
| IT1219652B (it) * | 1987-06-23 | 1990-05-24 | Sandoz Ag | 8-acilamminoergolina,la sua preparazione e il suo impiego come medicamneto |
-
1985
- 1985-01-03 NL NL8500008A patent/NL193541C/nl not_active IP Right Cessation
- 1985-01-03 HU HU8524A patent/HU197569B/hu unknown
- 1985-01-03 CH CH16/85A patent/CH664568A5/de not_active IP Right Cessation
- 1985-01-05 DE DE3500251A patent/DE3500251C2/de not_active Expired - Fee Related
- 1985-01-07 FR FR8500217A patent/FR2560196B1/fr not_active Expired
- 1985-01-08 GB GB08500454A patent/GB2152507B/en not_active Expired
- 1985-01-08 BE BE1/11168A patent/BE901456A/fr not_active IP Right Cessation
- 1985-01-10 PT PT79818A patent/PT79818B/pt not_active IP Right Cessation
- 1985-01-10 CA CA000471859A patent/CA1245640A/en not_active Expired
- 1985-01-10 LU LU85725A patent/LU85725A1/fr unknown
- 1985-01-10 IE IE6485A patent/IE58228B1/en not_active IP Right Cessation
- 1985-01-10 SE SE8500107A patent/SE460420B/sv not_active IP Right Cessation
- 1985-01-10 GR GR850065A patent/GR850065B/el unknown
- 1985-01-10 DK DK012685A patent/DK169891B1/da active
- 1985-01-11 JP JP60003913A patent/JPH0655739B2/ja not_active Expired - Lifetime
- 1985-01-11 ZA ZA85276A patent/ZA85276B/xx unknown
- 1985-01-11 IL IL74043A patent/IL74043A/xx not_active IP Right Cessation
- 1985-01-11 NZ NZ210818A patent/NZ210818A/xx unknown
- 1985-01-11 IT IT8547538A patent/IT1214648B/it active
- 1985-01-11 AT AT0005985A patent/AT391317B/de not_active IP Right Cessation
- 1985-01-11 ES ES539511A patent/ES8605514A1/es not_active Expired
- 1985-01-11 AU AU37609/85A patent/AU583489B2/en not_active Ceased
- 1985-01-11 FI FI850130A patent/FI82466C/fi not_active IP Right Cessation
- 1985-01-14 PH PH31714A patent/PH23286A/en unknown
-
1988
- 1988-11-11 AU AU25067/88A patent/AU618290B2/en not_active Ceased
- 1988-11-11 AU AU25066/88A patent/AU609539B2/en not_active Ceased
-
1989
- 1989-02-27 US US07/316,363 patent/US4950672A/en not_active Expired - Fee Related
-
1990
- 1990-05-02 SG SG32390A patent/SG32390G/en unknown
- 1990-06-21 HK HK485/90A patent/HK48590A/xx not_active IP Right Cessation
- 1990-07-02 US US07/547,899 patent/US5077298A/en not_active Expired - Lifetime
-
1991
- 1991-03-22 CY CY1542A patent/CY1542A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE1002212A5 (fr) | Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments. | |
| BE901456A (fr) | Nouvelles 8 alpha-acylaminoergolines, leur preparation et leur utilisation comme medicaments. | |
| IL99145A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| FR2639636B1 (fr) | Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant | |
| DK0687266T3 (da) | Heterocykliske forbindelser og deres fremstilling og anvendelse | |
| BE1002211A4 (fr) | (pentamethyl-1,2,2,6,6 piperidyl-4-amino)-triazines, leur application comme stabilisants de matieres organiques, et compositions qui en contiennent. | |
| NO930600L (no) | Heterocykliske forbindelser og deres fremstilling og anvendelse | |
| MY101784A (en) | Novel pharmacological compounds | |
| AU531586B2 (en) | Morpholine derivatives | |
| ES8604128A1 (es) | Un procedimiento para la preparacion de nuevos derivados de bencenosulfonamida | |
| BE900594A (fr) | Nouveaux composes azoliques, leur preparation et leur utilisation comme antifongiques et fongicides. | |
| BE904796A (fr) | Nouveaux derives du morphinane et de la morphine, leur preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant. | |
| EP0229444A3 (en) | Medicaments for the treatment of anxiety | |
| FR2388793A1 (fr) | Azetidinyl-acetonitriles et -acetamides, compositions antiarythmiques contenant ces composes et utilisation de ces compositions | |
| FR2407212A1 (fr) | Isochromanes, isothiochromanes, 2-benzoxepines et 2-benzothiepines et medicament en contenant | |
| OA07063A (fr) | Nouveaux dérivés d'aminéothoxy-4 isopropy-5 méthyl-2 phénol, leur méthodes de préparation et leur emploi comme médicaments. | |
| FR2456104A1 (fr) | Nouvelles pyrazinobenzodiazepines, leur preparation et leur application comme medicaments | |
| OA07539A (fr) | Nouveaux dérivés d'acides phényl aliphatiques, leur préparation, leur application comme médicaments, et les compositions les renfermant. | |
| CA2161297A1 (fr) | Nouveaux derives de la diosmetine, leur procede de preparation et les compositions pharmaceutiques les contenant | |
| BE902914A (fr) | Nouveaux composes naphtaleniques, leur preparation et leur application comme medicaments | |
| BE1000245A3 (fr) | Nouveaux derives de la purine, leur preparation et leur utilisation comme medicaments. | |
| ZA872664B (en) | Six-membered heterocyclic derivatives of n'-substituted-n,n'-diacylhydrazines | |
| IE870845L (en) | N'-substituted-n,n'-diacylhydrazines | |
| ES548330A0 (es) | Un metodo de preparacion de un compuesto de tiadiazina | |
| BE902600A (fr) | Derives de naphtoxazine, leur preparation, leur application comme medicaments et compositions pharmaceutiques les contenant. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: NOVARTIS A.G. Effective date: 20000131 |